Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis

European Journal of Medical Research

Volumn 12, Issue 1, 2007, Pages 26-33

  Schiffl, H ^a  

^a KfH Nierenzentrum München Laim ^*  (Germany)

Author keywords

Dialysis fluid; High flux haemodialysis; Online haemodiafiltration

Indexed keywords

BETA 2 MICROGLOBULIN; BUFFER; PHOSPHATE; RECOMBINANT ERYTHROPOIETIN; UREA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG RESPONSE; ENERGY BALANCE; FATALITY; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; HYPOTENSION; INCIDENCE; INTERMETHOD COMPARISON; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SODIUM BALANCE;

ADULT; AGED; CALCIUM; CROSS-OVER STUDIES; ERYTHROPOIETIN; FEMALE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PHOSPHATES; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RENAL DIALYSIS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; UREA;

EID: 33847205345     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Baz M, Durand C, Ragon A, Jaber K, Andrieu D, Metzouk T, Purgus R, Olmer M, Reynier JP, Berland Y (1991) Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 14: 681-685
2. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK (2006) Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results fromx the DOPPS. Kidney Int 69: 2087-93
3. Canaud B, Morena M, Leray-Moragues H, Chalabi L, Cristol JP (2006) Overview of clinical studies in hemodiafiltration: what do we need now? Hemodial Int 10 Suppl 1:S5-S12
4. Cheung AK, Rocco MV, Yan G, Levpoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G (2006) Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17: 546-555
5. Donauer J, Schweiger C, Rumberger B, Krumme B, Bohler J (2003) Reduction of hypotensive side effects during online-haemodiafiltration and low temperature haemodialysis. Nephrol Dial Transplant 18: 1616-1622
6. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019
7. Hsu PY, Lin CL, Yu CC, Chien CC, Hsiau TG, Sun TH, Huang LM, Yang CW (2004) Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study. J Nephrol 17: 693-700
8. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T (1997) Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 52: 1096-1101
9. Kuchle C, Fricke H, Held E, Schiffl H (1996) High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. Am J Nephrol 16: 484-488
10. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini G (1996) Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 50: 1293-1302
11. Locatelli F, Ponti R, Pedrini L, Di Filippo S (1990) Adequate sodium balance and cardiovascular stability. Nephrol Dial Transplant 5 (suppl 1): 141-143
12. Maduell F (2005) Hemodiafiltration. Hemodial Int 9: 47-55
13. Maggiore Q, Pizzarelli F, Dattolo P, Maggiore U, Cerrai T (2000) Cardiovascular stability during haemodialysis, haemofiltration and haemodiafiltration. Nephrol Dial Transplant 15 Suppl 1: 68-73
14. Nakai S, Iseki K, Tabei K, Kubo K, Masakane I, Fushimi K, Kikuchi K, Shinzato T, Sanaka T, Akiba T (2001) Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis 38: S212-S216
15. Rabindranath KS, Strippoli GF, Roderick P, Wallace SA, MacLeod AM, Daly C (2005) Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. Am J Kidney Dis 45: 437-447
16. Schiffl H, Lang SM, Bergner A (1999) Ultrapure dialysate reduces dose of recombinant human erythropoietin. Nephron 83: 278-279
17. Schiffl H, Lang SM, Stratakis D, Fischer R (2001) Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrology Dialysis Transplantation 16: 1863-1869
18. Spalding E, Farrington K (2003) Haemodiafiltration: current status. Nephron Clin Pract 93: c87-c96
19. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J (2006) On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 24: 163-173
20. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W (2000) A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11: 2344-2350
21. Wizemann V, Lotz C, Techert F, Uthoff S (2000) On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 15 Suppl 1: 43-48
22. Zehnder C, Gutzwiller JP, Renggli K (1999) Hemodiafiltration - a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 52: 152-159